Oncolytic viruses successfully delivered intravenously.
D061605:Administration, Intravenous / Q000379:methods*; D001688:Biological Products / Q000008:administration & dosage* / Q000493:pharmacokinetics*; D015179:Colorectal Neoplasms / Q000628:therapy; D006801:Humans; D008113:Liver Neoplasms / Q000556:secondary / Q000628:therapy; D050504:Oncolytic Viruses / Q000254:growth & development*; D018165:Orthoreovirus / Q000254:growth & development*
D001688:Biological Products